BPMC - Tasty Short BPMC
With indexes showing bearish potential, this is quite a tasty looking short setup here as this stock has just had a big earnings gap up today.
This appears to be a 1:1.618 ABC with an Ending Diagonal.
Ending Diagonal is is just an ascending wedge at the end of an impulse wave.
Notice the bearish divergence on the week chart.
That tends to be very significant.
This hasn't quite reached the 1.618 which is @ $111.44.
You could just short here but that is where the fib is and its probably odds on to hit it.
If it does I have a limit short order there.
If it did top out at the 1.618 then I think it can get back the the 0.618 retracement @$57.
I wouldn't hold the short that long but this could be quite a severe downtrend coming 👍.
Not advice
BPMC trade ideas
💊 Blueprint Medicines: Positive Momentum and Growth Prospects! 📊 Analysis NASDAQ:BPMC :
Financial Performance: 90% YoY growth in net-product revenues from U.S. sales of Ayvakit, a drug for certain cancers.
Market Prospects: Positive market response to Ayvakit's unique clinical profile.
CEO's Confidence: CEO's confidence in the company's future contributes to its momentum.
📈 Bullish Sentiment:
Entry Range: Suggested entry above the $83.00-$84.00 range.
Upside Target: Aiming for an upside in the $120.00-$125.00 range.
🌐 Note: Monitor BPMC's ongoing developments and market performance! 📊💹 #BPMC #Biotech #BullishSentiment 💊📈
BPMC - head and shoulder championThis chart seems to love itself. Infatuated with its very own "Head and Shoulders" multiple times looking back on the daily!
Waiting for this one to fill out completely before entering puts. No entry without confirmation. Inside channel, recent bounce off weekly resistance point forming its head. Will wait for pinbar to form on support level right where the shoulder fills out to complete this pattern. Also zooming in on it as it gets closer will work with the TRND bot indicators for additional confirmations. Trade smart!
Please like/follow if you like these ideas! I appreciate any input
$BPMCEntry price : 106.83
Fundamentals :
- Sector: Medical - Biotech
- EPS % Chg (Last Qtr): 678%
- EPS % Chg (Previous Qtr): -11.64%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 8053%
- Sales % Chg (Previous Qtr): 63%
- 3-Year Sales Growth Rate: 91%
- Annual Pre -Tax Margin: -522.8%
BPMC, enters Downtrend as Momentum drops below 0 level on Nov 18This indicator may be signaling that BPMC's price has further to drop, since it fell below its price logged 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options. Tickeron's A.I.dvisor backtested 79 similar cases where BPMC's Momentum Indicator fell below the 0 level, and 70 of them led to a successful outcome. Odds of Success: 89%. Current price $98.02 crossed the support line at $95.79 and is trading between $98.91 resistance and $95.79 support lines. Throughout the month of 10/20/20 - 11/19/20, the price experienced a -6% Downtrend. During the week of 11/12/20 - 11/19/20, the stock fell -4%.
Bearish Trend Analysis
The 10-day RSI Indicator for BPMC moved out of overbought territory on October 30, 2020. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 27 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.
The Momentum Indicator moved below the 0 level on November 18, 2020. You may want to consider selling the stock, shorting the stock, or exploring put options on BPMC as a result. In 69 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for BPMC turned negative on October 21, 2020. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 42 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where Apple declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
BPMC: BUY DIPS 50% gains // SWING trade (STOCKS)Why get subbed to to me on Tradingview?
-TOP author on TradingView
-15+ years experience in markets
-Professional chart break downs
-Supply/Demand Zones
-TD9 counts / combo review
-Key S/R levels
-No junk on my charts
-Frequent updates
-Covering FX/crypto/US stocks
-24/7 uptime so constant updates
BPMC: BUY DIPS 50% gains // SWING trade (STOCKS)
IMPORTANT NOTE: speculative setup. do your own
due dill. use STOP LOSS. don't overleverage.
🔸 Summary and potential trade setup
::: BPMC weekly chart overview
::: strong bullish chart
::: expecting strong gains after dip
::: next SWING is going to be 50%+ gains
::: well defined range so buy lows now
::: STRATEGY: BUY DIPS near 65 USD
::: BUY/HOLD swing trade setup / patient traders
::: 50% gains on BUY SIDE 4-16 weeks max
::: TO BULLS is 100 USD / share
::: good luck traders
🔸 Supply/Demand Zones
::: N/A
::: N/A
🔸 Other noteworthy technicals/fundies
::: TD9/Combo update: N/A
::: Sentiment: BULLS
::: Sentiment outlook short-term: BULLS
$BPMC can rise in the next daysContextual immersion trading strategy idea.
Blueprint Medicines Corporation develops drugs of small molecule kinase inhibitors that target genomic drivers in genomically defined cancers, rare diseases, and cancer immunotherapy.
The share prose rose after the company had announced the deal with pharma giant Roche (RHHBY) to sell a cancer treatment, pralsetinib.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $79,21;
stop-loss — $76,47.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Blueprint Medicines Corp. Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
BMPQ Put SpreadBMPQ Short Spread,
Cost $1.93
75/70 Exp October 18
Max loss is $125 max gain is $200
Spread is moderate cost reward ratio is decent.
Trending lower however it may hold sideways here and rise we'll see how it pans out. It may fall under its own weight a little bit more into a support zone.
$BPMC BLUEPRINT MEDICINES SWINGS 30% TO UPSIDE THIS WEEKALTHOUGH THE STOCK HAS JUMPED THIS WEEK, IT IS NOT TO LATE TO GET IN, BUYING PRESSURE IS IMMENSE AND THE STOCK HAS A EASY 50% UPSIDE POTENTIAL LEFT IN THE TANK, ON THE BACK OF GROWING EXPECTATION THE COMPANY WILL HAVE ITS FIRST APPROVED DRUG FOR SALE AND AT LAST GENERATE PROFITS .
AVERAGE ANALYSTS PRICE TARGET $118
AVERAGE ANALYSTS RECOMMENDATION BUY
COMPANY PROFILE
Blueprint Medicines Corp. is a precision therapy company, which focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.
Going long BPMC on ThursdayBPMC is printing a bullish full-body hammer candlestick over candlestick price bar on heavier above average volume with my momentum/trending oscillators confirming the price move. I am going long BPMC on Thursday using a limit (GTC-BUY-LMT) order @ 76.00. I will have one trailing sell stop (GTC-SELL-STP) @ 70.82 to protect my initial invested capital in case BPMC does not move higher immediately. I am expecting a measured move similar to all or part of the previous uptrend from the December '16 - December '17 uptrend.
BPMC - Long - Swing- non break-out volume is on the low side
- overall bear market in the past few days w/ high volatility
- price range is a bit wider than ideal
+ broke out today under extreme high volume
+ support from both fast and slow ema
+ narrowing of bollinger band
+ 5ema pierced through the middle of the body
+ Consecutive NR3 of prior days
+ bullish trend intensity
+ MACD Crossover upward
+ sideway price movement over the past weeks
: Strategy - if triggered, exit half position on entry+1 day